Recent insider trading activity from Hewes L. Becker, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Damora Therapeutics, Inc. | $DMRA | Hewes L. Becker | Chief Medical Officer | A | Common Stock | 264629 | $0.00 | 264,629.0000 | 1,327,212 | 9999.99% | 19.94% |
| Jan. 5, 2026 | Damora Therapeutics, Inc. | $DMRA | Hewes L. Becker | Chief Medical Officer | A | Stock Option (right to buy) | 528603 | $0.00 | 528,603.0000 | 1,327,212 | 9999.99% | 39.83% |